...
首页> 外文期刊>Bulletin of experimental biology and medicine >Changes in tissue metalloproteinase inhibitor-1 and matrix metalloproteinases during tumor development and metastasizing in mice.
【24h】

Changes in tissue metalloproteinase inhibitor-1 and matrix metalloproteinases during tumor development and metastasizing in mice.

机译:肿瘤发育过程中组织金属蛋白酶抑制剂-1和基质金属蛋白酶的变化,小鼠转移。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Tissue inhibitor of matrix metalloproteinases type 1, inhibiting the majority of matrix metalloproteinases, can both suppress and stimulate tumor growth. The concentrations and activities of tissue matrix metalloproteinase inhibitor-1 were measured in C57Bl/6 mice during progression and metastasizing of Lewis lung adenocarcinoma. Activities of matrix metalloproteinases in tumor tissue of mice were lower than in liver and lung tissues of intact animals. Serum concentration of tissue inhibitor increased significantly during the development of Lewis lung adenocarcinoma. Macrophage depression (injection of gadolinium chloride associated with a decrease in metastasis number) decreased serum concentration of tissue inhibitor, but it did not attain the control level observed in intact mice. These findings attest to a pleiotropic antitumor effect of tissue matrix metalloproteinase inhibitor-1 reflecting disorders in matrix metalloproteinase regulation during the progress of Lewis lung adenocarcinoma in mice.
机译:基质金属蛋白酶的组织抑制剂1型,抑制大多数基质金属蛋白酶,可以抑制和刺激肿瘤生长。在Lewis肺腺癌的进展和转移期间,在C57BL / 6小鼠中测量组织基质金属蛋白酶抑制剂-1的浓度和活性。小鼠肿瘤组织中的基质金属蛋白酶的活性低于完整动物的肝脏和肺组织。路易斯肺腺癌的发育过程中组织抑制剂的血清浓度显着增加。巨噬细胞抑郁(注射与转移数减少的氯化钆)降低了组织抑制剂的血清浓度,但它没有达到在完整小鼠中观察到的对照水平。这些调查结果证明了组织基质金属蛋白酶抑制剂-1反射疾病在小鼠Lewis肺腺癌进展期间的基质金属蛋白酶调节中的抗脂肪抗肿瘤作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号